Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001387131-22-008888

Chief Executive Officer bought 94,849,203 shares at $0.97 ($92,003,727)

From the SEC's structured data for this filing

Trades in this filing

DUGGAN ROBERT W · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-08-16 Purchase : show line 1 in the form +94,849,203 $0.97 $92,003,727 162,532,792 D
Open-market purchases · 94,849,203 sh · avg $0.97 · $92,003,727
Loading xslF345X03/duggan-form4_081622.xml…